Insider Trading Activity - Invus Advisors L.L.C.

Real time insider trading transaction history:

Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
Shares are not adjusted for stock split.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Insider Trading Transactions for Invus Advisors L.L.C.

Common stock purchase or sale:

Transaction Date	Reported DateTime	Company	Symbol	Insider Relationship	Shares Traded	Average Price	Total Amount	Shares Owned	Filing
2023-06-05 Purchase	2023-06-05 4:46 pm	LEXICON PHARMACEUTICALS INC.	LXRX	Artal International S.C.A. Wittouck Amaury Artal International Management S.A. Artal Group S.A. Westend S.A. Stichting Administratiekantoor Westend Invus Public Equities L.P. Invus L.P. Invus Public Equities Advisors LLC Invus Advisors L.L.C. Director 10% Owner	27,775,050	$2.6	$72,215,130	117,553,284 (Indirect)	View
2022-08-05 Purchase	2022-08-09 4:46 pm	LEXICON PHARMACEUTICALS INC.	LXRX	Artal International S.C.A. Wittouck Amaury Artal International Management S.A. Artal Group S.A. Westend S.A. Stichting Administratiekantoor Westend Invus Public Equities L.P. Invus L.P. Invus Public Equities Advisors LLC Invus Advisors L.L.C. Director 10% Owner	2,426,070	$2.5	$6,065,175	89,778,234 (Indirect)	View
2022-08-01 Purchase	2022-08-01 4:15 pm	LEXICON PHARMACEUTICALS INC.	LXRX	Artal International S.C.A. Wittouck Amaury Artal International Management S.A. Artal Group S.A. Westend S.A. Stichting Administratiekantoor Westend Invus Public Equities L.P. Invus L.P. Invus Public Equities Advisors LLC Invus Advisors L.L.C. Director 10% Owner	16,173,800	$2.5	$40,434,500	87,352,164 (Indirect)	View
2020-12-16 Purchase	2020-12-17 2:39 pm	LEXICON PHARMACEUTICALS INC.	LXRX	Invus Public Equities L.P. Artal Treasury Ltd Invus L.P. Invus Public Equities Advisors LLC Invus Advisors L.L.C. Director 10% Owner	10,937,500	$3.2	$35,000,000	71,178,364 (Indirect)	View

Stock options: Exercise, Award, Grant, Conversion

Transaction Date	Reported DateTime	Exercisable Expiration	Company	Symnbol	Insider Relationship	Shares Traded	Conversion Price	Shares Owned	Filing
2024-05-10 Option Award	2024-05-14 5:17 pm	N/A N/A	LEXICON PHARMACEUTICALS INC.	LXRX	Artal International S.C.A. Wittouck Amaury Artal International Management S.A. Artal Group S.A. Westend S.A. Stichting Administratiekantoor Westend Invus Public Equities L.P. Invus L.P. Invus Public Equities Advisors LLC Invus Advisors L.L.C. Director 10% Owner	1,150,922	$108.5	176,250,306 (Indirect)	View
2024-05-10 Exercise	2024-05-14 5:17 pm	N/A N/A	LEXICON PHARMACEUTICALS INC.	LXRX	Artal International S.C.A. Wittouck Amaury Artal International Management S.A. Artal Group S.A. Westend S.A. Stichting Administratiekantoor Westend Invus Public Equities L.P. Invus L.P. Invus Public Equities Advisors LLC Invus Advisors L.L.C. Director 10% Owner	58,697,022	$0	176,250,306 (Indirect)	View
2024-03-13 Option Award	2024-03-13 9:22 pm	N/A N/A	LEXICON PHARMACEUTICALS INC.	LXRX	Artal International S.C.A. Wittouck Amaury Artal International Management S.A. Artal Group S.A. Westend S.A. Stichting Administratiekantoor Westend Invus Public Equities L.P. Invus L.P. Invus Public Equities Advisors LLC Invus Advisors L.L.C. Director 10% Owner	1,150,922	$108.5	1,150,922 (Indirect)	View

Insider Trading & Ownership - Invus Advisors L.L.C.